Technology appraisal TA217 Alzheimer's disease – donepezil, galantamine, rivastigmine and memantine
This guidance replaces NICE technology appraisal guidance 111 issued in November 2006 (amended September 2007, August 2009). Read more »
You are exploring: Prescribing
Alzheimer’s drugs to be made available to all
The final NICE guidance means the drugs Aricept, Exelon and Reminyl will be available on prescription to people in the early and moderate stages of Alzheimer’s and Ebixa will be available to people in the late stages. Read more »
Improving the prescribing of antipsychotic drugs for people with dementia
Details of a letter from Sir Ian Carruthers, Chief Executive of NHS South West and Jeremy Hughes, Chief Executive of the Alzheimer’s Society, to SHA Chief Executives to invite them to adapt four recommendations to drive down inappropriate prescribing antipsychotic medication and providing alternative ways of working and interventions that improve the safety, quality of life and outcomes for people with dementia. Read more »
Implementing national priorities next steps
Sir Ian Carruthers, Chief Executive of NHS South West, recently wrote to South West Chief Executives and South West Directors of Adult Social Care outlining the next steps on implementing the four national priorities set out in Quality outcomes in dementia. Read more »
Psychotropic medicine management for people in care homes with dementia
This guidance aims to support the safe management of psychotropic medicines in Norfolk care homes particularly when given to residents to assist in managing their psychological agitation. Read more »
Audit of antipsychotic therapy in dementia patients in Hampshire
This audit of antipsychotic therapy in patients with dementia was undertaken by NHS Hampshire to ensure it is safe and complies with local guidance. Read more »
Prescribing review: Acetyl Cholinesterase inhibitors
This audit was undertaken by North Staffordshire Combined Healthcare NHS Trust to establish compliance with NICE Technology Appraisal Guidance 111 on the use of donepezil, galantamine and rivastigmine for the treatment of mild to moderately severe Alzheimer’s disease. Read more »
Improving the prescribing of antipsychotic drugs for people with dementia
Sir Ian Carruthers, Chief Executive of NHS South West and Jeremy Hughes, Chief Executive of the Alzheimer’s Society recently wrote to SHA Chief Executives to invite their participation in work to accelerate improvements in local practice in prescribing antipsychotic drugs for people with dementia, which will be funded by the Department of Health. Read more »
Care home sets up 1950s room for Alzheimer's patients
Coombe End Court care home in Wiltshire has created a ‘time warp’ room that contains features from the 1950s to help aid the memories of Alzheimer’s patients. Read more »
Living well with dementia bulletin, Issue 3, October 2010
The third issue of the Living Well with Dementia bulletin provides features on achievements in implementing the National Dementia Strategy across the South West of England. This includes work to raise awareness, improving early diagnosis and early intervention, delivering better dementia care in general hospitals and care homes and developing an informed and effective workforce for people with dementia. Read more »